| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 10/08/2013 | US8551965 Anti-viral pyrimidine nucleoside analogues |
| 10/08/2013 | US8551959 Glycolipid and use thereof |
| 10/03/2013 | WO2013146833A1 SALT OF 1-(2-DEOXY-2-FLUORO-4-THIO-β-D-ARABINOFURANOSYL)CYTOSINE |
| 10/03/2013 | WO2013144894A1 Nucleoside analogue as an anticancer compound |
| 10/03/2013 | US20130261294 Novel Crystalline Forms Of An Antiviral Benzimidazole Compound |
| 10/03/2013 | US20130261073 Modulator of activity of adenylate cyclase |
| 10/03/2013 | US20130261026 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| 10/03/2013 | US20130259831 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-Oxazolo and 3H-Thiazolo[4,5-d]pyrimidin-2-one Compounds and Prodrugs Thereof |
| 10/02/2013 | EP2644614A2 Solid state forms of 5-azacytidine and processes for preparation thereof |
| 10/02/2013 | CN103339139A 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| 10/02/2013 | CN103333215A Synthetic method of 2-fluoroadenosine |
| 10/02/2013 | CN103331035A Method for decolorizing nucleotide enzymatic hydrolysate |
| 10/02/2013 | CN102212097B Synthetic method of decitabine |
| 10/01/2013 | US8546557 Methods of making nucleoside tetraphosphate analogs |
| 10/01/2013 | US8546344 Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole |
| 10/01/2013 | US8546309 Monomeric and polymeric linkers useful for conjugating biological molecules and other substances |
| 10/01/2013 | CA2533367C Purine nucleoside analogues for treating flaviviridae including hepatitis c |
| 09/26/2013 | WO2013142125A1 Methods of preparing substituted nucleotide analogs |
| 09/26/2013 | WO2013142124A1 Solid forms of a thiophosphoramidate nucleotide prodrug |
| 09/26/2013 | WO2013141350A1 Oligosaccharide compound, manufacturing method therefor, and intermediate thereof |
| 09/26/2013 | WO2009152353A3 Reversible nucleosides and nucleotides terminators and their use in dna sequencing |
| 09/26/2013 | US20130253181 Methods of preparing substituted nucleotide analogs |
| 09/26/2013 | US20130253178 2'-o-modified rna |
| 09/26/2013 | US20130253034 2'-Arabino-Fluorooligonucleotide N3'-->P5' Phosphoramidates: Their Synthesis and Use |
| 09/26/2013 | US20130252919 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders |
| 09/26/2013 | US20130252918 Phosphoramidite derivatives of gemcitabine for use in the treatment cancer |
| 09/26/2013 | US20130251637 Fluorescent compounds |
| 09/25/2013 | EP2640426A1 Immunostimulatory oligonucleotides |
| 09/25/2013 | CN103319557A Crystallization method of cyclic adenosine monophosphate |
| 09/25/2013 | CN103319556A Method for chemically preparing 2'-desoxyadenossine |
| 09/25/2013 | CN103319555A Preparation method of 2'-methoxy adenosine |
| 09/25/2013 | CN103319554A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/25/2013 | CN102167716B Synthesis method of clofarabine, midbody thereof and preparation method of midbody |
| 09/24/2013 | US8541570 Methods and compositions for labeling nucleic acids |
| 09/24/2013 | US8541562 Bridged artificial nucleoside and nucleotide |
| 09/24/2013 | CA2670328C Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 09/24/2013 | CA2575737C Tanaproget derivatives, metabolites, and uses thereof |
| 09/19/2013 | WO2013138236A1 2'- substituted carba-nucleoside analogs for antiviral treatment |
| 09/19/2013 | WO2013137427A1 Novel pyrimidine nucleoside compound |
| 09/19/2013 | WO2013135900A1 Tricyclic nucleosides and oligomeric compounds prepared therefrom |
| 09/19/2013 | WO2013061105A8 Glycogen phosphorylase inhibitors |
| 09/19/2013 | US20130244968 Uracyl Spirooxetane Nucleoside Phosphoramidates |
| 09/19/2013 | US20130243725 2'-substituted carba-nucleoside analogs for antiviral treatment |
| 09/18/2013 | EP2639238A1 Tricyclic nucleosides and oligomeric compounds prepared therefrom |
| 09/18/2013 | EP2638054A1 Uracyl spirooxetane nucleoside phosphoramidates |
| 09/18/2013 | EP2638053A1 Uracyl spirooxetane nucleoside phosphoramidates |
| 09/18/2013 | CN103314001A Novel synthesis of nucleoside 5'-triphosphates and their derivatives |
| 09/18/2013 | CN103304613A Method for separating and purifying four nucleoside chemical ingredients from trichosanthes bark |
| 09/18/2013 | CN101557725B Flavour modulating derivative of a carboxylic acid and a purine, pyrimidine, nucleoside or nucleotide |
| 09/17/2013 | US8536323 Modified nucleotides |
| 09/17/2013 | US8536319 Compounds and methods for detecting ricin and uses thereof |
| 09/17/2013 | US8535885 Detection of disease related genes |
| 09/17/2013 | CA2632626E Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection |
| 09/17/2013 | CA2574088C Oligonucleotides comprising a modified or non-natural nucleobase |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/17/2013 | CA2445381C Phosphorous antimicrobial compounds and methods for their use |
| 09/12/2013 | WO2013132489A1 Nucleoside 5'-phosphorothioate analogues and uses thereof |
| 09/12/2013 | US20130237697 Building blocks and methods for the synthesis of 5-hydroxymethylcytosine-containing nucleic acids |
| 09/12/2013 | US20130237495 Cdk-inhibiting pyrrolopyrimidinone carboxamide derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing the same as active ingredient for preventing or treating hepatocellular carcinoma |
| 09/12/2013 | US20130237492 Use of 2',5'-oligoadenylate derivative compounds |
| 09/12/2013 | US20130237491 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 09/11/2013 | EP2636677A1 Cdk-inhibiting pyrrolopyrimidinone carboxamide derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating liver cell cancer |
| 09/11/2013 | CN103288909A Method for extracting cordycepin from cordyceps sinensis fresh culture medium |
| 09/11/2013 | CN103288908A Preparation method of cytidine and cytidine derivatives |
| 09/11/2013 | CN103288907A Synthetic method for 2', 3'-bisdeoxyuridine |
| 09/11/2013 | CN103288906A A 3,5 - bis-O-benzoyl-2-C-methyl-C-methyl C-4 - (1,2,4 - triazolyl) uridine and a synthesis method thereof |
| 09/11/2013 | CN103288905A Novel technology for synthesis of capecitabine |
| 09/11/2013 | CN102276378B Treatment method of fermentation broth |
| 09/11/2013 | CN101830955B Synthesizing process of antineoplastic agent clofarabine |
| 09/11/2013 | CN101573370B HCV nucleoside inhibitor |
| 09/10/2013 | US8530640 Bicyclic cyclohexitol nucleic acid analogs |
| 09/10/2013 | US8530156 Chemically cleavable phosphoramidite linkers for sequencing by ligation |
| 09/10/2013 | US8530154 System and method for nucleic acid sequencing by polymerase synthesis |
| 09/10/2013 | CA2627837C Pharmaceutical compositions for alleviating discomfort |
| 09/10/2013 | CA2589529C 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 09/06/2013 | WO2013128393A1 A process for preparing pure citicoline (cdp-choline) |
| 09/04/2013 | EP2634263A1 Charge-switch nucleotides based method for sequencing of nucleic acids |
| 09/04/2013 | CN103275159A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/04/2013 | CN103275158A Methods for preparing decitabine |
| 09/04/2013 | CN103275157A Rupestonic acid amide derivative containing heterocyclic ring and sugar, preparation method and purposes thereof |
| 09/04/2013 | CN103275156A Rupestonic acid ester derivatives containing heterocycle and glycosyl and preparation methods and applications thereof |
| 09/04/2013 | CN103271934A Sea cucumber extract containing alkaloids active ingredients as well as extracting method and application thereof |
| 09/03/2013 | US8524883 Monohydrate of (1-{9-[4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide |
| 08/29/2013 | US20130225520 Uracyl Spirooxetane Nucleoside Phosphoramidates |
| 08/29/2013 | US20130225519 Nucleoside phosphoramidates |
| 08/28/2013 | EP2631239A1 2',4'-substituted nucleosides as antiviral agents |
| 08/28/2013 | EP2630152A1 Nucleotide analogue, method of synthesis of nucleotide analogue, use of nucleotide analogue, antiviral pro-nucleotide, pharmaceutical composition |
| 08/28/2013 | CN103270043A Process for the preparation of morpholinyl anthracycline derivatives |
| 08/28/2013 | CN103265595A Method for extracting S-adenosylmethionine from brewing yeast fermentation broth |
| 08/28/2013 | CN103265594A Garcinia acid amide derivative and preparation method thereof and purpose |
| 08/27/2013 | US8519115 Stable nanoreporters |
| 08/27/2013 | US8518901 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 08/27/2013 | CA2706222C Light-responsive artificial nucleotide having photo-crosslinking ability |
| 08/22/2013 | WO2013068850A3 PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES |
| 08/22/2013 | US20130217648 Uracyl Spirooxetane Nucleosides |
| 08/22/2013 | US20130217643 Method of reducing intraocular pressure in humans |
| 08/21/2013 | CN103254333A Ultrahigh cross-linked resin SX-01 and application thereof |
| 08/21/2013 | CN103254260A Method for synthesizing symmetric dinucleoside diphosphate disodium salt from nucleoside hydrogen phosphite monoester |
| 08/21/2013 | CN102088982B Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine |
| 08/21/2013 | CN101883569B Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |